Be Biopharma, Inc. raised $82 million in a financing round to transition to a clinical-stage company for its engineered B Cell Medicines.
Amount Raised
$82 Million
Round Type
Funding Round
CambridgeInformation TechnologyBiotechnologySoftwareData And AnalyticsScience And EngineeringDescription
Be Biopharma, Inc. announced the financing as it advances its lead program, BE-101 for Hemophilia B, into clinical trials. The company aims to transform treatment for patients with few therapeutic options.
Quick answer
Be Biopharma raised $82 Million in a Funding Round round, dated October 22, 2024. Be Biopharma is based in Cambridge, Massachusetts, United States.
- How much did Be Biopharma raise?
- Be Biopharma raised $82 Million in a Funding Round round on October 22, 2024.
- What does Be Biopharma do?
- Be Biopharma (“Be Bio”) is pioneering Engineered B Cell Medicines (BCMs) to dramatically improve the lives of patients who are living with Hemophilia B and other genetic diseases, cancer, and other serious conditions.
- Where is Be Biopharma based and how big is it?
- Be Biopharma is based in Cambridge, Massachusetts, United States.
- Who are the decision-makers at Be Biopharma?
- Fundz holds 1 contact at Be Biopharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Data And Analytics and Science And Engineering around the same time
Companies in the same sectors as Be Biopharma that raised within 45 days of this round, from Fundz verified event records.
- ArrePath raised $1.3M (Seed) on November 19, 2024.
- Lilt raised $45M on November 15, 2024.
- Cornerstone AI raised $5M (Series A) on October 30, 2024.
- Neuron7.ai raised $45M on September 27, 2024.
- PBS Biotech raised $8.5M on September 11, 2024.
- CardiaTec raised $6.5M (Seed) on September 10, 2024.
Who to call at Be Biopharma, and when
A new round usually means Be Biopharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Be Biopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Be Biopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Be Biopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Be Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Be Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.